Search Results - "Dietrich, Y."

Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness by Cosset, E, Petty, T, Dutoit, V, Tirefort, D, Otten-Hernandez, P, Farinelli, L, Dietrich, P.-Y, Preynat-Seauve, O

“…Abstract Glioblastoma multiforme (GBM) is among the most aggressive cancers associated with massive infiltration of peritumoral parenchyma by migrating tumor…”
Get full text

Control of laser plasma accelerated electrons for light sources by André, T., Andriyash, I. A., Loulergue, A., Labat, M., Roussel, E., Ghaith, A., Khojoyan, M., Thaury, C., Valléau, M., Briquez, F., Marteau, F., Tavakoli, K., N’Gotta, P., Dietrich, Y., Lambert, G., Malka, V., Benabderrahmane, C., Vétéran, J., Chapuis, L., El Ajjouri, T., Sebdaoui, M., Hubert, N., Marcouillé, O., Berteaud, P., Leclercq, N., El Ajjouri, M., Rommeluère, P., Bouvet, F., Duval, J. -P., Kitegi, C., Blache, F., Mahieu, B., Corde, S., Gautier, J., Ta Phuoc, K., Goddet, J. P., Lestrade, A., Herbeaux, C., Évain, C., Szwaj, C., Bielawski, S., Tafzi, A., Rousseau, P., Smartsev, S., Polack, F., Dennetière, D., Bourassin-Bouchet, C., De Oliveira, C., Couprie, M.-E.

“…With gigaelectron-volts per centimetre energy gains and femtosecond electron beams, laser wakefield acceleration (LWFA) is a promising candidate for…”
Get full text

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma by Hottinger, A F, Aissa, A B, Espeli, V, Squiban, D, Dunkel, N, Vargas, M I, Hundsberger, T, Mach, N, Schaller, K, Weber, D C, Bodmer, A, Dietrich, P-Y

“…Background: Sorafenib (Sb) is a multiple kinase inhibitor targeting both tumour cell proliferation and angiogenesis that may further act as a potent…”
Get full text

Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome by Favero, F., McGranahan, N., Salm, M., Birkbak, N.J., Sanborn, J.Z., Benz, S.C., Becq, J., Peden, J.F., Kingsbury, Z., Grocok, R.J., Humphray, S., Bentley, D., Spencer-Dene, B., Gutteridge, A., Brada, M., Roger, S., Dietrich, P.-Y., Forshew, T., Gerlinger, M., Rowan, A., Stamp, G., Eklund, A.C., Szallasi, Z., Swanton, C.

“…In a glioblastoma tumour with multi-region sequencing before and after recurrence, we find an IDH1 mutation that is clonal in the primary but lost at…”
Get full text

Ipilimumab-related hypophysitis may precede severe CNS immune attack by Köessler, T., Olivier, T., Fertani, S., Marinari, E., Dutoit, V., Dietrich, P.-Y.

“…Reintroduction of ipilimumab after recovery or hormonal substitution for hypophysitis should be carefully done especially in the presence of minor neurological…”
Get full text

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse by Brada, M., Hoang-Xuan, K., Rampling, R., Dietrich, P-Y., Dirix, L. Y., Macdonald, D., Heimans, J. J., Zonnenberg, B. A., Bravo-Marques, J. M., Henriksson, R., Stupp, R., Yue, N., Bruner, J., Dugan, M., Rao, S., Zaknoen, S.

“…Background: Recurrent glioblastoma multiforme (GBM) is resistant to most therapeutic endeavors, with low response rates and survival rarely exceeding six…”
Get full text

Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome by Dietrich, P.-Y., Duchosal, M.A.

Get full text

Tunable High Spatio-Spectral Purity Undulator Radiation from a Transported Laser Plasma Accelerated Electron Beam by Ghaith, A., Oumbarek, D., Roussel, E., Corde, S., Labat, M., André, T., Loulergue, A., Andriyash, I. A., Chubar, O., Kononenko, O., Smartsev, S., Marcouillé, O., Kitégi, C., Marteau, F., Valléau, M., Thaury, C., Gautier, J., Sebban, S., Tafzi, A., Blache, F., Briquez, F., Tavakoli, K., Carcy, A., Bouvet, F., Dietrich, Y., Lambert, G., Hubert, N., El Ajjouri, M., Polack, F., Dennetière, D., Leclercq, N., Rommeluère, P., Duval, J.-P., Sebdaoui, M., Bourgoin, C., Lestrade, A., Benabderrahmane, C., Vétéran, J., Berteaud, P., De Oliveira, C., Goddet, J. P., Herbeaux, C., Szwaj, C., Bielawski, S., Malka, V., Couprie, M.-E.

“…Undulator based synchrotron light sources and Free Electron Lasers (FELs) are valuable modern probes of matter with high temporal and spatial resolution. Laser…”
Get full text

Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers by Stupp, R., Hottinger, A. F., van den Bent, M. J., Dietrich, P. -Y., Brandes, A. A.

Get full text

Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas by Jenny, B, Harrison, JA, Baetens, D, Tille, J-C, Burkhardt, K, Mottaz, H, Kiss, JZ, Dietrich, P-Y, De Tribolet, N, Pizzolato, GP, Pepper, MS

“…Primary human brain tumours account for approximately 2% of all cancers. High levels of expression of vascular endothelial growth factor‐A (VEGF‐A), a potent…”
Get full text

Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital by Loubeyre, P, McKee, T A, Copercini, M, Rosset, A, Dietrich, P-Y

“…We evaluated the diagnostic quality of image-guided multisampling core needle biopsy (CNB) in patients investigated for suspected lymphoma in a primary care…”
Get full text

Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back by Walker, P R, Saas, P, Dietrich, P Y

“…Several different tumor types have recently been shown to express functional Fas ligand (FasL), which may represent an additional mechanism of tumor escape…”
Get full text

Publisher Correction: Control of laser plasma accelerated electrons for light sources by André, T., Andriyash, I. A., Loulergue, A., Labat, M., Roussel, E., Ghaith, A., Khojoyan, M., Thaury, C., Valléau, M., Briquez, F., Marteau, F., Tavakoli, K., N’Gotta, P., Dietrich, Y., Lambert, G., Malka, V., Benabderrahmane, C., Vétéran, J., Chapuis, L., El Ajjouri, T., Sebdaoui, M., Hubert, N., Marcouillé, O., Berteaud, P., Leclercq, N., El Ajjouri, M., Rommeluère, P., Bouvet, F., Duval, J. -P., Kitegi, C., Blache, F., Mahieu, B., Corde, S., Gautier, J., Ta Phuoc, K., Goddet, J. P., Lestrade, A., Herbeaux, C., Évain, C., Szwaj, C., Bielawski, S., Tafzi, A., Rousseau, P., Smartsev, S., Polack, F., Dennetière, D., Bourassin-Bouchet, C., De Oliveira, C., Couprie, M. -E.

“…The original version of this Article contained an error in the last sentence of the first paragraph of the Introduction and incorrectly read ‘A proper electron…”
Get full text

Tumors that look for their springtime in APRIL by Roosnek, E, Burjanadze, M, Dietrich, P.Y, Matthes, T, Passweg, J, Huard, B

“…Abstract Inflammatory cells produce a proliferation inducing ligand (APRIL), one of the most recently cloned members of the tumor necrosis factor (TNF) family…”
Get full text

Bortezomib-induced skin eruption by Sanchez-Politta, S, Favet, L, Kerl, K, Dietrich, P-Y, Piguet, V

“…Bortezomib (Velcad) is a proteasome inhibitor recently developed and mainly used for the treatment of multiple myeloma. Bortezomib represents a novel class of…”
Get more information

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? by Saas, P, Walker, P R, Hahne, M, Quiquerez, A L, Schnuriger, V, Perrin, G, French, L, Van Meir, E G, de Tribolet, N, Tschopp, J, Dietrich, P Y

“…Astrocytomas are among the most common brain tumors that are usually fatal in their malignant form. They appear to progress without significant impedance from…”
Get full text

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 by Marchand, Marie, van Baren, Nicolas, Weynants, Patrick, Brichard, Vincent, Dréno, Brigitte, Tessier, Marie‐Hélène, Rankin, Elaine, Parmiani, Giorgio, Arienti, Flavio, Humblet, Yves, Bourlond, André, Vanwijck, Romain, Liénard, Danielle, Beauduin, Marc, Dietrich, Pierre‐Yves, Russo, Vincenzo, Kerger, Joseph, Masucci, Giuseppe, Jäger, Elke, De Greve, Jacques, Atzpodien, Jens, Brasseur, Francis, Coulie, Pierre G., van der Bruggen, Pierre, Boon, Thierry

“…Thirty‐nine tumor‐bearing patients with metastatic melanoma were treated with 3 subcutaneous injections of the MAGE‐3.A1 peptide at monthly intervals. No…”
Get full text

Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva) by Lübbe, J, Masouyé, I, Dietrich, P Y

“…Erlotinib is a small molecule tyrosine kinase inhibitor that is used as an anticancer agent. Most patients develop a pustular facial dermatitis within the…”
Get more information

Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient : Case Report and Literature Review by Tschanz, E., Benhammane, Hafida, Dietrich, P. Y., El Mesbahi, O., Mentha, G.

“…Background. Kaposi’s sarcoma (KS) in transplant recipients is about 400 to 500 times rate in the general population. It is strongly associated to Human…”
Get full text

Prevention of mucositis in bone marrow transplantation: A double blind randomised controlled trial of sucralfate by Castagna, L., Benhamou, E., Pedraza, E., Luboinski, M., Forni, M., Brandes, I., Pico, J.-L., Dietrich, P.-Y.

“…Mucositis is still a leading side effect of high dose chemotherapy and irradiation delivered in autologous and allogeneic bone marrow transplantation. In this…”
Get full text